PL1664033T3 - Analogi 9,10-alfa, alfa-OH-taksanu i sposoby ich wytwarzania - Google Patents

Analogi 9,10-alfa, alfa-OH-taksanu i sposoby ich wytwarzania

Info

Publication number
PL1664033T3
PL1664033T3 PL04789167T PL04789167T PL1664033T3 PL 1664033 T3 PL1664033 T3 PL 1664033T3 PL 04789167 T PL04789167 T PL 04789167T PL 04789167 T PL04789167 T PL 04789167T PL 1664033 T3 PL1664033 T3 PL 1664033T3
Authority
PL
Poland
Prior art keywords
alpha
group
hydroxyl
methods
taxane analogs
Prior art date
Application number
PL04789167T
Other languages
English (en)
Polish (pl)
Inventor
James D Mcchesney
James Ferrara
Jan Zygmut
Original Assignee
Tapestry Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tapestry Pharmaceuticals Inc filed Critical Tapestry Pharmaceuticals Inc
Publication of PL1664033T3 publication Critical patent/PL1664033T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL04789167T 2003-09-25 2004-09-27 Analogi 9,10-alfa, alfa-OH-taksanu i sposoby ich wytwarzania PL1664033T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50668003P 2003-09-25 2003-09-25
PCT/US2004/031816 WO2005030150A2 (en) 2003-09-25 2004-09-27 9,10-α,α-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THEREOF
EP04789167A EP1664033B1 (en) 2003-09-25 2004-09-27 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof

Publications (1)

Publication Number Publication Date
PL1664033T3 true PL1664033T3 (pl) 2008-04-30

Family

ID=34393186

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04789167T PL1664033T3 (pl) 2003-09-25 2004-09-27 Analogi 9,10-alfa, alfa-OH-taksanu i sposoby ich wytwarzania

Country Status (14)

Country Link
US (8) US7745650B2 (enExample)
EP (2) EP1785416A3 (enExample)
JP (5) JP4874102B2 (enExample)
CN (1) CN1886400A (enExample)
AT (1) ATE377593T1 (enExample)
AU (1) AU2004275881A1 (enExample)
CA (1) CA2539975C (enExample)
DE (1) DE602004009943T2 (enExample)
DK (1) DK1664033T3 (enExample)
ES (1) ES2295937T3 (enExample)
HR (1) HRP20080057T3 (enExample)
PL (1) PL1664033T3 (enExample)
PT (1) PT1664033E (enExample)
WO (1) WO2005030150A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1785416A3 (en) 2003-09-25 2007-05-30 Tapestry Pharmaceuticals, Inc. 9, 10-alpha, alpha-OH-Taxane Analogs and methods for production thereof
JP2008536479A (ja) 2005-02-11 2008-09-11 ユニバーシティ オブ サザン カリフォルニア ジスルフィド架橋を有するタンパク質の発現法
CA2634453A1 (en) * 2005-12-21 2007-06-28 Tapestry Pharmaceuticals, Inc. Novel compounds and methods for forming taxanes and using the same
MX2008008119A (es) * 2005-12-21 2008-09-24 Tapestry Pharmaceuticals Inc Procesos para derivados de taxano y compuestos intermedios utiles en los mismos.
WO2007126893A2 (en) * 2006-03-27 2007-11-08 Tapestry Pharmaceuticals, Inc. A convergent process for the synthesis of taxane derivatives
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
US7847111B2 (en) 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
WO2007143839A1 (en) * 2006-06-12 2007-12-21 6570763 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel and 10-deacetylbaccatin iii from 9-dihydro-13-acetylbaccatin iii
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
WO2008109360A1 (en) * 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US8802394B2 (en) 2008-11-13 2014-08-12 Radu O. Minea Method of expressing proteins with disulfide bridges with enhanced yields and activity
EP2694055A4 (en) * 2011-04-07 2014-09-10 Arbor Therapeutics Llc ANALOGUES OF TAXANE AND ABÉO-TAXANE
US9227983B2 (en) 2011-04-07 2016-01-05 Arbor Therapeutics, LLC Taxane and abeo-taxane analogs
MX337464B (es) * 2011-06-06 2016-03-07 Arbor Therapeutics Llc Profarmacos lipofilicos labiles al acido de los agentes quimioterapeuticos contra el cancer.
AU2021231831A1 (en) 2020-03-04 2022-09-08 Aquedeon Medical, Inc. Vascular and aortic grafts with telescoping sheath and deployment methods thereof
US12622797B2 (en) 2021-03-04 2026-05-12 Aquedeon Medical, Inc. Vascular and aortic connectors with robotic delivery and deployment methods thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US6794523B2 (en) * 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
DE69325454T2 (de) * 1992-04-17 2000-01-20 Abbott Laboratories, Abbott Park Taxol-derivate
FR2697019B1 (fr) * 1992-10-15 1994-11-25 Rhone Poulenc Rorer Sa Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
EP0668762B1 (en) * 1992-11-13 2003-09-17 Florida State University Isobutenyl-substituted taxanes and their pharmaceutical compositions
US6710191B2 (en) * 1993-03-05 2004-03-23 Florida State University 9β-hydroxytetracyclic taxanes
EP0687260B1 (en) * 1993-03-05 2003-02-19 Florida State University Process for the preparation of 9-desoxotaxanes
EP1148055A1 (en) * 1993-03-05 2001-10-24 Florida State University C9 taxane derivatives and pharmaceutical compositions containing them
DK0690867T3 (da) 1993-03-22 2003-06-10 Univ Florida State Taxaner med furyl- eller thienylsubstitueret sidekæde
FR2707293A1 (fr) * 1993-07-08 1995-01-13 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2715846A1 (fr) * 1994-02-07 1995-08-11 Rhone Poulenc Rorer Sa Nouvelle composition pharmceutique à base de taxoïdes.
IT1275936B1 (it) 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5739359A (en) * 1997-01-24 1998-04-14 Virginia Tech Intellectual Properties, Inc. Methods for preparing 1-deoxy paclitaxels
US6048990A (en) * 1998-05-01 2000-04-11 Napro Biotherapeutics, Inc. Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
HUP0200750A3 (en) * 2000-02-02 2005-02-28 Univ Florida State Res Found C10 heterosubstituted acetate taxanes as antitumor agents and pharmaceutical compositions containing them and their use
EP1383492A4 (en) 2001-03-23 2008-12-24 Napro Biotherapeutics Inc MOLECULAR CONJUGATES FOR USE IN CANCER THERAPY
CA2354471A1 (en) 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
EP1465618A2 (en) 2001-12-20 2004-10-13 Bristol-Myers Squibb Company Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
US6898834B1 (en) * 2003-03-03 2005-05-31 Westbridge Pty Ltd Barrel stave reclaim
EP1894921A3 (en) 2003-09-25 2008-03-12 Tapestry Pharmaceuticals, Inc. 9, 10-Alpha, Alpha-Oh-Taxane analogs and methods for production thereof
EP1785416A3 (en) * 2003-09-25 2007-05-30 Tapestry Pharmaceuticals, Inc. 9, 10-alpha, alpha-OH-Taxane Analogs and methods for production thereof
AU2006247471A1 (en) 2005-05-12 2006-11-23 Tapestry Pharmaceuticals, Inc. Molecular constructs suitable for targeted conjugates
MX2008008119A (es) 2005-12-21 2008-09-24 Tapestry Pharmaceuticals Inc Procesos para derivados de taxano y compuestos intermedios utiles en los mismos.
CA2634453A1 (en) 2005-12-21 2007-06-28 Tapestry Pharmaceuticals, Inc. Novel compounds and methods for forming taxanes and using the same
WO2007126893A2 (en) 2006-03-27 2007-11-08 Tapestry Pharmaceuticals, Inc. A convergent process for the synthesis of taxane derivatives
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008109360A1 (en) 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US20080207743A1 (en) 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment

Also Published As

Publication number Publication date
JP5525394B2 (ja) 2014-06-18
US7745650B2 (en) 2010-06-29
JP2016180006A (ja) 2016-10-13
US9402824B2 (en) 2016-08-02
JP2007506792A (ja) 2007-03-22
AU2004275881A1 (en) 2005-04-07
EP1664033B1 (en) 2007-11-07
US20190142784A1 (en) 2019-05-16
JP2011012070A (ja) 2011-01-20
JP2014196345A (ja) 2014-10-16
JP4874102B2 (ja) 2012-02-15
US20120077871A1 (en) 2012-03-29
US10238621B2 (en) 2019-03-26
EP1785416A3 (en) 2007-05-30
US7879904B2 (en) 2011-02-01
US9820962B2 (en) 2017-11-21
JP5629632B2 (ja) 2014-11-26
US20050148657A1 (en) 2005-07-07
EP1785416A2 (en) 2007-05-16
JP2011137045A (ja) 2011-07-14
DE602004009943T2 (de) 2008-08-28
US20100324128A1 (en) 2010-12-23
JP6106634B2 (ja) 2017-04-05
EP1664033A4 (en) 2006-09-13
US20200237708A1 (en) 2020-07-30
CA2539975C (en) 2012-11-20
EP1664033A2 (en) 2006-06-07
US8962870B2 (en) 2015-02-24
CA2539975A1 (en) 2005-04-07
US20180125811A1 (en) 2018-05-10
ATE377593T1 (de) 2007-11-15
US20160331718A1 (en) 2016-11-17
DK1664033T3 (da) 2008-03-25
US20150133536A1 (en) 2015-05-14
CN1886400A (zh) 2006-12-27
US10639293B2 (en) 2020-05-05
DE602004009943D1 (de) 2007-12-20
JP6216417B2 (ja) 2017-10-18
PT1664033E (pt) 2008-01-17
HRP20080057T3 (en) 2008-02-29
WO2005030150A3 (en) 2005-07-14
ES2295937T3 (es) 2008-04-16
WO2005030150A2 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
PT1664033E (pt) Análogos de 9,1o-a,a-oh-taxanos e processos para sua produção
TW410228B (en) Phosphonooxymethyl ethers of taxane derivatives
DE60220422D1 (de) Substituierte pyrazoloverbindungen zur behandlung von entzündungen
WO2004084812A3 (en) Tamandarin analogs and fragments thereof and methods of making and using
ATE543494T1 (de) Griseofulvin-analoga zur behandlung von krebs durch hemmung von zentrosomaler clusterbildung
MX2021000089A (es) Derivados de fenil-n-quinolina para el tratamiento de una infeccion por virus de acido ribonucleico (arn).
DE50308114D1 (de) Verfahren zur herstellung von 6-alkoxy-(6h)-dibenz(c,e)(1,2)-oxaphosphorinen
EA014959B3 (ru) Ингибиторы глицинового переносчика-1
ATE458484T1 (de) ßVERFAHREN UND ZWISCHENPRODUKTE ZUR HERSTELLUNG VON STATINEN; INSBESONDERE VON ROSUVASTATINß
ATE527270T1 (de) Herstellung von organosilanestern
ATE372332T1 (de) Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga
EP1810968A3 (en) 9, 10-a, a-OH-taxane analogs and methods for production thereof
DE602004020667D1 (en) Prostaglandinsynthese
BRPI0712192A2 (pt) Composição de poliolefina, mistura-padrão processo para produção de um artigo, artigo, uso de uma composição de poliolefina e uso de um composto contendo silício
DE602004014769D1 (de) Reaktive flammschutzmittel und flammgeschützte harzprodukte
WO2004103967A3 (en) Thiocarbamate inhibitors of alpha-4 integrins
ATE208381T1 (de) Verfahren zur herstellung von taxol und seiner derivate
NZ335105A (en) Process for alkylating hindered sulfonamides
ATE223414T1 (de) Prozess zur herstellung von zwischebprodukten für imidazodeazepinen
KR20060030063A (ko) 비스(트리메틸실록시)실릴알킬글리세롤 메타크릴레이트의제조방법
GB0320738D0 (en) Novel process
ATE523198T1 (de) Pyrroloä2,3-düpyrimidine zur behandlung von krebs durch mitosehemmung
DE602004020050D1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
GB0316268D0 (en) Process for preparing cyclic organohydrogensiloxanes
TW200720282A (en) Novel organosilicon compound and process for producing the same